134 related articles for article (PubMed ID: 17916085)
1. Downregulation of neuropilin-1 in patients with acute myeloid leukemia treated with thalidomide.
Kreuter M; Steins M; Woelke K; Buechner T; Berdel WE; Mesters RM
Eur J Haematol; 2007 Nov; 79(5):392-7. PubMed ID: 17916085
[TBL] [Abstract][Full Text] [Related]
2. Correlation of neuropilin-1 overexpression to survival in acute myeloid leukemia.
Kreuter M; Woelke K; Bieker R; Schliemann C; Steins M; Buechner T; Berdel WE; Mesters RM
Leukemia; 2006 Nov; 20(11):1950-4. PubMed ID: 16990775
[TBL] [Abstract][Full Text] [Related]
3. Tumor angiogenesis in the bone marrow of multiple myeloma patients and its alteration by thalidomide treatment.
Du W; Hattori Y; Hashiguchi A; Kondoh K; Hozumi N; Ikeda Y; Sakamoto M; Hata J; Yamada T
Pathol Int; 2004 May; 54(5):285-94. PubMed ID: 15086832
[TBL] [Abstract][Full Text] [Related]
4. [Expression and effect of neuropilin-1 in acute myeloid leukemic cells].
Lu L; Zhang L; Xiao ZJ; Lu SH; Wang GS; Yang RC; Han ZC
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Dec; 15(6):1150-5. PubMed ID: 18088455
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of basic fibroblast growth factor and autocrine stimulation in acute myeloid leukemia.
Bieker R; Padró T; Kramer J; Steins M; Kessler T; Retzlaff S; Herrera F; Kienast J; Berdel WE; Mesters RM
Cancer Res; 2003 Nov; 63(21):7241-6. PubMed ID: 14612519
[TBL] [Abstract][Full Text] [Related]
6. Role of neuropilin-1 and its expression in Egyptian acute myeloid and acute lymphoid leukemia patients.
Younan S; Elhoseiny S; Hammam A; Gawdat R; El-Wakil M; Fawzy M
Leuk Res; 2012 Feb; 36(2):169-73. PubMed ID: 21978468
[TBL] [Abstract][Full Text] [Related]
7. [Angiogenesis in patients with hematologic malignancies].
Mesters RM; Padró T; Steins M; Bieker R; Retzlaff S; Kessler T; Kienast J; Berdel WE
Onkologie; 2001 Sep; 24 Suppl 5():75-80. PubMed ID: 11600818
[TBL] [Abstract][Full Text] [Related]
8. Bone marrow angiogenesis and angiogenic factors in multiple myeloma treated with novel agents.
Cibeira MT; Rozman M; Segarra M; Lozano E; Rosiñol L; Cid MC; Filella X; Bladé J
Cytokine; 2008 Mar; 41(3):244-53. PubMed ID: 18178097
[TBL] [Abstract][Full Text] [Related]
9. Expression of the vascular endothelial growth factor receptor neuropilin-1 in the human endometrium.
Hess AP; Schanz A; Baston-Buest DM; Hirchenhain J; Stoff-Khalili MA; Bielfeld P; Kruessel JS
J Reprod Immunol; 2009 Jan; 79(2):129-36. PubMed ID: 18996601
[TBL] [Abstract][Full Text] [Related]
10. Expression of angiopoietins and their receptor Tie2 in the bone marrow of patients with acute myeloid leukemia.
Schliemann C; Bieker R; Padro T; Kessler T; Hintelmann H; Buchner T; Berdel WE; Mesters RM
Haematologica; 2006 Sep; 91(9):1203-11. PubMed ID: 16956819
[TBL] [Abstract][Full Text] [Related]
11. Phase I study of cladribine, cytarabine (Ara-C), granulocyte colony stimulating factor (G-CSF) (CLAG Regimen) and simultaneous escalating doses of imatinib mesylate (Gleevec) in relapsed/refractory AML.
Walker AR; Komrokji RS; Ifthikharuddin J; Messina P; Mulford D; Becker M; Friedberg J; Oliva J; Phillips G; Liesveld JL; Abboud C
Leuk Res; 2008 Dec; 32(12):1830-6. PubMed ID: 18571721
[TBL] [Abstract][Full Text] [Related]
12. [Evolution of gene expression profile in 3 cases of acute myeloid leukemia].
Tang JM; Meng FY; Ma WL
Zhonghua Xue Ye Xue Za Zhi; 2005 Nov; 26(11):653-5. PubMed ID: 16620549
[TBL] [Abstract][Full Text] [Related]
13. Response to thalidomide in multiple myeloma: impact of angiogenic factors.
Rosiñol L; Cibeira MT; Segarra M; Cid MC; Filella X; Aymerich M; Rozman M; Arenillas L; Esteve J; Bladé J; Montserrat E
Cytokine; 2004 May; 26(4):145-8. PubMed ID: 15149630
[TBL] [Abstract][Full Text] [Related]
14. Expression of neuropilin-1 in kidney graft biopsies: what is the significance?
Zhou H; Zhang L; Tong L; Cai M; Guo H; Yang C; Shi B; Chen ZK
Transplant Proc; 2007; 39(1):81-3. PubMed ID: 17275479
[TBL] [Abstract][Full Text] [Related]
15. A phase I study of bexarotene, a retinoic X receptor agonist, in non-M3 acute myeloid leukemia.
Tsai DE; Luger SM; Andreadis C; Vogl DT; Kemner A; Potuzak M; Goradia A; Loren AW; Perl AE; Schuster SJ; Porter DL; Stadtmauer EA; Goldstein SC; Thompson JE; Swider C; Bagg A; Mato AR; Carroll M
Clin Cancer Res; 2008 Sep; 14(17):5619-25. PubMed ID: 18765556
[TBL] [Abstract][Full Text] [Related]
16. Neuropilin-1 in acute myeloid leukemia: expression and role in proliferation and migration of leukemia cells.
Lu L; Zhang L; Xiao Z; Lu S; Yang R; Han ZC
Leuk Lymphoma; 2008 Feb; 49(2):331-8. PubMed ID: 18231921
[TBL] [Abstract][Full Text] [Related]
17. Combination of 5-azacytidine and thalidomide for the treatment of myelodysplastic syndromes and acute myeloid leukemia.
Raza A; Mehdi M; Mumtaz M; Ali F; Lascher S; Galili N
Cancer; 2008 Oct; 113(7):1596-604. PubMed ID: 18720364
[TBL] [Abstract][Full Text] [Related]
18. Thalidomide for the treatment of acute myeloid leukemia.
Steins MB; Bieker R; Padró T; Kessler T; Kienast J; Berdel WE; Mesters RM
Leuk Lymphoma; 2003 Sep; 44(9):1489-93. PubMed ID: 14565649
[TBL] [Abstract][Full Text] [Related]
19. NRP-1/CD304 expression in acute leukemia: a potential marker for minimal residual disease detection in precursor B-cell acute lymphoblastic leukemia.
Meyerson HJ; Blidaru G; Edinger A; Osei E; Schweitzer K; Fu P; Ho L
Am J Clin Pathol; 2012 Jan; 137(1):39-50. PubMed ID: 22180477
[TBL] [Abstract][Full Text] [Related]
20. Thalidomide in advanced hepatocellular carcinoma as antiangiogenic treatment approach: a phase I/II trial.
Pinter M; Wichlas M; Schmid K; Plank C; Müller C; Wrba F; Peck-Radosavljevic M
Eur J Gastroenterol Hepatol; 2008 Oct; 20(10):1012-9. PubMed ID: 18787470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
